Looking Ahead: An Actuarial Perspective on Long-Term CI Trends
With the pandemic entering a new phase, the question on the insurance industry’s mind is how the lingering effects impact actuarial assumptions. In this presentation, individuals from RGA’s Pricing and Strategic Research team walk you through key insights from the best available data and discuss the expected long-term impact of the pandemic on pricing and profitability.
SVP, Pricing and Strategic Research
VP, Global Actuarial Pricing and Research
Frontiers of Medical Innovation in CI
Critical Illness represents a fantastic canvas for innovation, and against the backdrop of significant gains in our medical understanding, the next generation of products is taking shape. RGA’s medical team will walk you through the new medical trends and how they are changing the way insurers think about new product design, risk management and strategy, as well as the role that medical teams play in winning proposition design.
VP, Senior Technical Global Medical Director
Regional Medical Director Asia Markets
VP, Head of Global Medical
Successfully Selling Digital Critical Illness Insurance in 2023 and Beyond: Lessons Learned
Technology has created limitless new possibilities for alternative distribution of CI and Supplemental Health products. But getting the interplay right between target customer, channel, and product is a sensitive balance when achieving commercial success. RGA’s innovation and product teams will take you through successful alternative distribution case studies and the lessons learned.
Market Development Director, RGAX UK
Head of Business Development